From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA facilitates research on earlier stages of Alzheimer's disease

from U.S. Food and Drug Administration

From Sept. 21: More than 5 million Americans have been diagnosed with Alzheimer's disease, which is the sixth leading cause of death in the United States and the most common cause of dementia among people 60 or older. Alzheimer's is an irreversible, progressive brain disease that slowly destroys memory and thinking skills. It eventually robs sufferers of the ability to perform even the simplest tasks of daily life. Despite years of intensive efforts by scientists to develop new safe and effective treatments for Alzheimer's, options remain limited. In the last 20 years, FDA has approved five drugs for the disease — the most recent one in 2003. Although the drugs can provide some benefit, more needs to be done. A recent development could bring better results. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063